v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

RISK FACTORS AND INCIDENCE OF PERIPHERAL NEUROPATHY AMONG PATIENTS WITH TYPE II DIABETES MELLITUS

AUTHORS:

Dr Mahnoor, Dr Mala Ibrahim, Dr Komal Zainab

ABSTRACT:

Aim: A study was conducted to assess the risk factors and incidence for diabetic neuropathy in DM2 patients, taking into account the increasing burden of type 2 (DM2) diabetes worldwide and associated microvascular and macro vascular complications. Place and Duration: In the Medicine Unit II of Services Hospital Lahore for six months duration from July 2019 to December 2019. Methods: Patients aged 30 years and older with DM2 were included in the study. Diabetic neuropathy symptoms (DNS) questionnaire was used to assess symptoms, and diabetic neuropathy (DNE) scores were used to assess clinical results. Results: A total of 273 patients were included. The average age was 57.8 ± 11.5. The distribution of men among women was 75% (202) and 25% (71), respectively. According to the DNS tool, 41.4% of patients were positive for the presence of neuropathy, and only 24.5% had neuropathy based on the DNE result. The percentage of men affected by neuropathy was higher than women. DNS results were positive in 43.1% of men and DNE only 27.2%. The duration of the disease was positively correlated with neuropathy. Neuropathy was more common in people with high systolic and diastolic blood pressure than DNS and DNE devices. Conclusion: The study showed a higher percentage of men affected by neuropathy. Therefore, a more detailed assessment should be made for older men with diabetes who have a longer duration of the disease. Lifestyle changes and careful testing should be considered as part of routine patient health education during follow-up visits. Key words: diabetic neuropathy test, symptomatic of diabetic neuropathy, peripheral neuropathy, prevalence, risk factors, type 2 diabetes

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.